Sodium aurothiomalate

Sodium aurothiomalate
Clinical data
Trade names	Myocrisin
AHFS/Drugs.com	Multum Consumer Information
License data	US FDA: Gold_sodium_thiomalate;
Pregnancy; category	AU: B2;
Routes of; administration	Intramuscular
ATC code	M01CB01 (WHO) ;
Legal status
Legal status	AU: S4 (Prescription only); CA: ℞-only; UK: POM (Prescription only); US: Discontinued;
Pharmacokinetic data
Protein binding	High
Elimination half-life	6-25 days
Excretion	Urine (60-90%), faeces (10-40%)
Identifiers
	IUPAC name Sodium 2-(auriosulfanyl)-3-carboxypropanoate;
CAS Number	12244-57-4;
PubChem CID	16760302;
ChemSpider	7827788 ;
UNII	E4768ZY6GM;
ChEBI	CHEBI:35863 ;
CompTox Dashboard (EPA)	DTXSID20896942 ;
ECHA InfoCard	100.032.242
Chemical and physical data
Formula	C4H4AuNaO4S
Molar mass	368.09 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES [Au+].[Na+].[O-]C(=O)C([S-])CC(=O)O;
	InChI InChI=1S/C4H6O4S.Au.Na/c5-3(6)1-2(9)4(7)8;;/h2,9H,1H2,(H,5,6)(H,7,8);;/q;2*+1/p-2 ; Key:LTEMOXGFFHXNNS-UHFFFAOYSA-L ;
	(verify)

Sodium aurothiomalate (INN, known in the United States as gold sodium thiomalate) is a gold compound that is used for its immunosuppressive anti-rheumatic effects. Along with an orally-administered gold salt, auranofin, it is one of only two gold compounds currently employed in modern medicine.